Speaking Engagements
Research
Ketamine assisted psychotherapy for pMads (postpartum mood and anxiety disorders)
A community case series published in Frontiers in Psychiatry in January 2026. This study highlights the potential role of ketamine assisted psychotherapy as part of an integrative treatment plan for parents with PMADS (perinatal mood and anxiety disorders).
Psilocybin in Palliative care: an update
This 5 year review published in Current Geriatric Reports in 2023 offered a summary of the potential role for psilocybin in addressing at the end of life and during life-limiting illness.
ketamine assisted psychotherapy for problematic substance use
A retrospective case series published in Frontiers in Psychiatry in 2023. This paper describes findings from five years of ketamine assisted psychotherapy (KAP) among those with active or past problematic substance use.
Dr. Whinkin & colleagues at the 2023 cannabis science conference
Discussing the judicious use of psychedelics for healing and growth with educators, scientists, providers and others.
Media Features
Dr. Whinkin interviewed by Karolyn A. Gazella of the Natural Medicine Journal regarding psilocybin’s knowns, unknowns, and potential in October 2023
Dr. Whinkin featured in a January 2024 Integrative Practitioner article regarding clinical applications of ketamine
Listen to the Podcast:
‘Advising Patients About Ketamine Use in Clinical Practice’
Dr. Whinkin featured in November 2023 National Geographic article by Meryl Davids Landau about ketamine.